Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas

被引：6
|
作者：
Yilmaz, Elif [1 ]
Lakhotia, Rahul [2 ]
Pittaluga, Stefania [3 ]
Muppidi, Jagan R. [2 ]
Phelan, James D. [2 ]
Evans, Sarah [2 ]
Pradhan, Amynah [2 ]
Hillsman, Amy [2 ]
Steinberg, Seth M. [4 ]
Jaffe, Elaine S. [3 ]
Wilson, Wyndham H. [2 ]
Roschewski, Mark [2 ]
Melani, Christopher [2 ]
机构：
[1] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, MD USA
[2] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[3] NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA
[4] NCI, Biostat & Data Management Sect, NIH, Bethesda, MD 20892 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-151824
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4504
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders (LPD) and EBV-Positive Non-Hodgkin Lymphomas (NHL)
    Dalela, Disha
    Lakhotia, Rahul
    Pittaluga, Stefania
    Muppidi, Jagan
    Steinberg, Seth
    Phelan, James
    Evans, Sarah
    Pradhan, Amynah
    Jaffe, Elaine
    Wilson, Wyndham
    Roschewski, Mark
    Melani, Christopher
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S451 - S451
  • [2] Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma
    Gandhi, MK
    Lambley, E
    Burrows, J
    Dua, U
    Elliott, S
    Shaw, PJ
    Prince, HM
    Wolf, M
    Clarke, K
    Underhill, C
    Mills, T
    Mollee, P
    Gill, D
    Marlton, P
    Seymour, JF
    Khanna, R
    CLINICAL CANCER RESEARCH, 2006, 12 (02) : 460 - 464
  • [3] Plasma Epstein-Barr Virus (EBV) DNA as a Biomarker for Diagnosis of EBV-positive Hodgkin Lymphoma in Syria
    Habeeb, Rana
    al Hafar, Lina
    Monem, Fawza
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (12): : 1917 - 1922
  • [4] Epstein-Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disorders
    Muti, G
    Klersy, C
    Baldanti, F
    Granata, S
    Oreste, P
    Pezzetti, L
    Gatti, M
    Gargantini, L
    Caramella, M
    Mancini, V
    Gerna, G
    Morra, E
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (06) : 927 - 933
  • [5] Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma
    Levin, Lynn I.
    Chang, Ellen T.
    Ambinder, Richard F.
    Lennette, Evelyne T.
    Rubertone, Mark V.
    Mann, Risa B.
    Borowitz, Michael
    Weir, Edward G.
    Abbondanzo, Susan L.
    Mueller, Nancy E.
    BLOOD, 2012, 120 (18) : 3750 - 3755
  • [6] Multiplex Epstein-Barr virus (EBV) serology in EBV-positive and -negative gastric cancer
    Camargo, M. Constanza
    Michel, Angelika
    Kim, Kyoung-Mee
    Matsuo, Keitaro
    Liao, Linda M.
    Torres, Javier
    Zabaleta, Jovanny
    Gulley, Margaret L.
    Yatabe, Yasushi
    Alvarado-Cabrero, Isabel
    Lissowska, Jolanta
    Kim, Sung
    Pawlita, Michael
    Rabkin, Charles S.
    CANCER RESEARCH, 2014, 74 (19)
  • [7] Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carcinoma
    Hoshikawa, Y
    Satoh, Y
    Murakami, M
    Maeta, M
    Kaibara, N
    Ito, H
    Kurata, T
    Sairenji, T
    JOURNAL OF MEDICAL VIROLOGY, 2002, 66 (03) : 351 - 359
  • [8] Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients
    Asano, Naoko
    Yamamoto, Kazuhito
    Tamaru, Jun-Ichi
    Oyama, Takashi
    Ishida, Fumihiro
    Ohshima, Koichi
    Yoshino, Tadashi
    Nakamura, Naoya
    Mori, Shigeo
    Yoshie, Osamu
    Shimoyama, Yoshie
    Morishima, Yasuo
    Kinoshita, Tomohiro
    Nakamura, Shigeo
    BLOOD, 2009, 113 (12) : 2629 - 2636
  • [9] Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma
    Timms, JM
    Bell, A
    Flavell, JR
    Murray, PG
    Rickinson, AB
    Traverse-Glehen, A
    Berger, F
    Delecluse, HJ
    LANCET, 2003, 361 (9353): : 217 - 223
  • [10] EPSTEIN-BARR-VIRUS (EBV)-ASSOCIATED LYMPHOPROLIFERATIVE DISEASE IN THE SCID MOUSE MODEL - IMPLICATIONS FOR THE PATHOGENESIS OF EBV-POSITIVE LYMPHOMAS IN MAN
    ROWE, M
    YOUNG, LS
    CROCKER, J
    STOKES, H
    HENDERSON, S
    RICKINSON, AB
    JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (01): : 147 - 158
12345